Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biologics
Pharma
Novartis telegraphs 130 job cuts in Switzerland
Novartis plans to discontinue small-volume biologics production at its Kleinbasel site by the end of 2027, in a move that could eliminate 130 jobs.
Angus Liu
Sep 2, 2026 2:15pm
Manufacturing hurdles stifle launches as biologics gain steam
May 15, 2026 9:20am
FDA unveils 1-day assessment pilot to complement inspections
May 6, 2026 3:08pm
Amgen adds $300M to US investment plan, targeting Puerto Rico
May 4, 2026 9:00am
Vertex taps Halozyme in $15M upfront biologics drug delivery deal
Apr 7, 2026 10:17am
Biogen taps Alteogen for help developing 2 subQ biologics
Mar 25, 2026 10:55am
